In one study, it has been confirmed that urinary levels of calbindin were significantly higher in patients with ATN, whereas lower in patients with prerenal AKI or HRS-AKI when compared to non-AKI patients [131]. This evidence concerns the gene CALB1 and oculocutaneous albinism type 1.